| 5HD4: reference: Dissecting Therapeutic Resistance to ERK Inhibition., Jha S, Morris EJ, Hruza A, Mansueto MS, Schroeder G, Arbanas J, McMasters D, Restaino CR, Dayananth P, Black S, Elsen NL, Mannarino A, Cooper A, Fawell S, Zawel L, Jayaraman L, Samatar AA, Mol Cancer Ther. 2016 Feb 1. pii: molcanther.0172.2015. PMID: 26832798 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).